From Beginning To End, FDA Transparency Weighed On Sharfstein’s Mind

As a lead player in FDA’s Transparency Initiative, outgoing Principal Deputy Commissioner Joshua Sharfstein helmed a task force that, on his penultimate day at the agency, unveiled a slew of measures to increase industry access to pertinent regulatory information.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet